Document Detail

The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function.
MedLine Citation:
PMID:  9083765     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: In RDS patients there is a significant drop of MAP, HR, MCBFV and FiO2 after bolus surfactant administration.
J A Schipper; G I Mohammad; H L van Straaten; J G Koppe
Related Documents :
10565465 - Nitric oxide inhalation inhibits pulmonary apoptosis but not inflammatory injury in por...
9310005 - Effect of volume recruitment on response to surfactant treatment in rabbits with lung i...
7816525 - Surfactant therapy and high-frequency jet ventilation in the management of a piglet mod...
8727565 - Effects of exogenous surfactant on lung pressure-volume characteristics during liquid v...
24505355 - Airway dysfunction in obesity: response to voluntary restoration of end expiratory lung...
492765 - An analysis of circadian rhythmicity of heart rate in tetraplegic human subjects.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pediatrics     Volume:  156     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1997 Mar 
Date Detail:
Created Date:  1997-06-25     Completed Date:  1997-06-25     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  224-7     Citation Subset:  IM    
Department of Neonatology, Academic Medical Centre/University of Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Airway Resistance / drug effects*,  physiology
Blood Flow Velocity / drug effects,  physiology
Brain / blood supply*
Functional Residual Capacity / drug effects
Hemodynamics / drug effects*,  physiology
Infant, Newborn
Oxygen / blood*
Pulmonary Surfactants / administration & dosage*,  adverse effects
Respiratory Distress Syndrome, Newborn / mortality,  physiopathology,  therapy*
Survival Rate
Treatment Outcome
Reg. No./Substance:
0/Pulmonary Surfactants; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia.
Next Document:  Arteriovenous malformation of the vein of Galen in three neonates: emphasis on associated early isch...